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Homocysteine: A potential molecular link between Alzheimer’s Disease and Type 2 Diabetes Mellitus 
 
Cyndel Carreau 
In order to elucidate some of the mechanisms through which Alzheimer’s disease (AD) and Type II 
Diabetes Mellitus (T2DM) are linked, this study investigated the effects of elevated plasma homocysteine 
levels – a risk factor for AD – in a rat model of T2DM.  Both elevated plasma homocysteine levels and 
T2DM are associated with cognitive deficits and are recognized as strong risk factors for the development 
of AD. The present experiment examined the effects of diet-induced hyperhomocysteinemia on the 
development of cognitive impairments and insulin-resistance, as well as on the insulin signaling cascade, 
in a diet-induced obese rat model of T2DM. Hyperhomocyteinemia was induced in both control-fed and 
high-fat diet plus fructose-fed (T2DM) animals using dietary supplementation of 2% methionine. 
Homocysteine levels were dramatically elevated in animals receiving methionine supplementation and a 
high-fat diet plus fructose and were significantly increased in animals receiving either high methionine or 
high fat plus fructose. Behavioral impairments were observed in all groups receiving treatment. Impaired 
glucose tolerance was observed in animals receiving either high methionine or high fat plus fructose diets; 
glucose intolerance was observed in animals receiving both treatments. Akt phosphorylation was reduced 
by 50% in groups receiving high methionine, regardless of high fat plus fructose. These findings strongly 
suggest that there are mechanisms at work by which homocysteine modulates the insulin signaling 
pathway and/or vice versa.  
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1. Introduction 
Elevated plasma homocysteine levels are associated with several cognitive impairments, including age-
related cognitive decline, cerebrovascular disease and stroke, and vascular dementia (Troen, 2005). More 
specifically, increased plasma homocysteine levels have been described as a strong, independent risk 
factor for Alzheimer’s disease (Seshadri et al., 2002). Zhuo et al. (2010) demonstrated that a diet high in 
methionine (the metabolic precursor of homocysteine) used to induce hyperhomocysteinemia, a condition 
in which blood homocysteine levels are abnormally elevated, accelerated the development of Alzheimer’s 
pathologies and behavioral impairments in APP transgenic mice, a mouse model of Alzheimer’s disease.  
Like elevated plasma homocysteine levels, type 2 diabetes mellitus is associated with cognitive deficits 
(Richardson, 1990) and is recognized as a strong risk factor for the development of Alzheimer’s disease 
(Ott et al., 1999). There is currently a lack of consensus about the relationship between plasma 
homocysteine levels and type 2 diabetes in the literature. Several studies have reported a positive 
correlation between insulin levels or insulin resistance and plasma homocysteine levels (Gallistl et al., 
2000; Sainani et al., 2009). Furthermore, insulin has been shown to inhibit the irreversible metabolism of 
homocysteine into cysteine through the trans-sulfuration pathway when methionine is in demand (Chieng 
et al., 2009).  
To elucidate some of the relationships between Alzheimer’s disease and type 2 diabetes, this study 
introduced the risk factor for Alzheimer’s disease, hyperhomocysteinemia, into a diet-induced obese rat 
model of type 2 diabetes. Hyperhomocysteinemia was induced using 2% supplementation of methionine 
in the diet. Fructose was added to the high fat diet with the intention of breaking the body’s correlation 
between food intake and caloric intake. Weight gain and food and water intake were monitored; body fat 
composition, serum homocysteine, and serum free fatty acids were quantitated; cognitive ability, glucose 
tolerance, and hippocampal protein activation were all measured.  
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2. Materials and Methods 
2.1. Animals 
All animal procedures were approved by the University at Albany IACUC and followed current protocol. 
Thirty-two male Sprague-Dawley rats (Charles River), 75 to 100 g (4 to 5 weeks old), were housed in 
pairs and kept on a 12h dark/light cycle with food and water available ad libitum. Following arrival in the 
Life Sciences Research Building Animal Care Facility, animals were given 2 to 6 days to acclimatize, 
after which diet administration began and continued for 10 weeks. Animal weights were obtained 1 to 2 
times per week. Animals were handled regularly prior to testing. 
2.2 Diets 
Animals were randomly assigned to one of four diets: normal chow (Purina, Prolab RMH 3000) and 
normal water; normal chow plus 2% additional methionine (Open Source Diets, C15122) and normal 
water; high fat chow (31.8% kcal from fat; Open Source Diets, D12266B) and high fructose water (20% 
fructose by weight); and high fat chow plus 2% additional methionine (Open Source Diets, D10122701) 
and high fructose water. High fructose water was made by dissolving crystalline D-(–)-fructose (Sigma-
Aldrich, F0127; MySpiceSage.com, #559) into tap water. Food and water intake were measured over a 
one-week period during the diet administration. 
2.3 Surgery 
After 8 weeks of diet administration, all animals underwent stereotactic surgery for placement of a 
microdialysis cannula into the left dorsal hippocampus. Animals were anesthetized using isofluorane. 
Upon exposure of the skull, a hole was drilled at coordinates x = +5.0 mm and y = ‒5.6 mm from bregma; 
a guide cannula (BASi, MD-2250; or CMA 12) was lowered to coordinate z = ‒3.0 mm from the dura. 
The guide cannula was sealed in place using dental cement. Animals were given 8 to 11 days post-surgery 
recovery prior to behavioral testing. 
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2.4 Behavioral testing and microdialysis 
Animals were subjected to a spatial cognitive task during week 9 of diet administration. The task 
consisted of running a four-arm elevated plus-maze from which a spontaneous alternation score was 
generated. Animals were placed in the center of the maze and allowed to freely explore its arms for 20 
minutes. Arm entries were recorded for each animal. Animals spontaneously alternate between arms, 
normally entering those which they have entered the least recently. An alternation is counted when the rat 
visits all four arms within any span of five consecutive arm choices; the maximum number of alternations 
is N – 4, where N is the total number of arms entered. The actual number of alternations made is 
expressed as a percentage of this number, with chance level at 44%. Animals which performed less than 
14 arm entries during the task were omitted from the results.  
Preceding, during, and following the course of the above-described spatial cognitive task, microdialysis 
samples from the hippocampus were collected using a 4 mm probe (BASi, IBR-4; or CMA 12), inserted 
into the guide cannula, for analysis of the metabolic state of the hippocampus during testing. Extracellular 
cerebrospinal fluid containing a physiological concentration of glucose (1.25mM) was used as a 
perfusate. Samples were collected at a rate of 2.0 µL/minute over 20 minute intervals, with baseline 
lasting 1 hour (3 samples), the maze task lasting 20 minutes (1 sample), and post-maze period lasting 1 
hour (3 samples); a one-hour equilibrium sample was also collected prior to baseline. Samples were 
frozen at -80 °C until analyzed for glucose using a CMA 600 Microdialysis Analyser.  
Following the spatial cognitive task and completion of microdialysis sample collection, animals were 
subjected to a second task, which consisted of running an open-field maze (1 m by 1 m box marked into 
16 [12 peripheral and 4 center] equal-sized squares). Animals were placed in the center of the maze and 
allowed to freely explore the box. Crossings from square to square were recorded for each animal. An 
open-field score was generated by placing the sum of crossings into or between center squares over the 
sum total of crossings. Lower open-field scores are correlated with increased anxiety behavior.  
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2.5 Glucose tolerance test 
Blood glucose was initially measured using a blood glucose meter (OneTouch Ultra Mini Monitor) during 
the week preceding surgery; blood was obtained by tail-prick.  
Either the day of or the day following behavioral testing, a glucose tolerance test was performed on each 
animal. Animals were given an intra-peritoneal (I.P.) injection of 1g/kg body weight D-(+)-glucose 
(Sigma-Aldrich, G8270), dissolved at concentration of 20% by weight in dH2O. Blood glucose was 
measured using a blood glucose meter at 0 minutes (baseline, prior to injection), 30 minutes after 
injection, and 60 minutes after injection. Blood was obtained by cutting the tip of the tail and “milking” 
the tail until a drop appeared at the tip. 
2.6 Brain, trunk blood, and epididymal fat pad collections 
Either the day of or the day following behavioral testing, animals were killed by decapitation following 
anesthesia by isoflurane. Whole brain was collected and immediately frozen on dry ice. Trunk blood was 
collected on ice and shaken to prevent clotting; within 30 minutes of collection, plasma was spun down at 
3000 rpm for 15 minutes and the serum fraction was collected for analysis. Epididymal fat pads were 
harvested from the carcass following trunk blood collection and weighed.  
2.7 Serum analyses 
Serum samples from each animal were sent to the Albany Medical Center Department of Pathology and 
Laboratory Medicine for analysis of blood homocysteine and free fatty acid levels. Homocysteine was 
detected using the ARCHITECT Homocysteine immunoassay. Free fatty acids were detected using 
spectrophotometry. 
2.8 Western blotting 
Hippocampal brain tissue was dissected from frozen whole brain then homogenized using a Polytron 
homogenizer into three volumes of homogenization buffer (BioVision, from kit K268-50) containing 
phosphotase and protease inhibitors. For total homogenate fraction, 30µL of homogenate was added to 
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200 µL of RIPA buffer containing phosphotase and protease inhibitors. The remaining non-total fraction 
homogenate was used to obtain the plasma membrane fraction. Plasma membrane protein extraction was 
carried out using the BioVision Plasma Membrane Protein Extraction kit (K268-50) according to the 
instructions provided with the kit. A BCA assay (Pierce, 23225) was carried out on both total and plasma 
membrane fractions.  
Precast 10% polyacrylamide gels (Biorad, Mini-PROTEAN TGX) were loaded with 20 µg of protein 
from each sample – to which 10 µL sample buffer containing 5% mercaptoethanol was added – per well 
and run in tris-glycine running buffer at 120V for 80 minutes. Total fraction samples to be probed for 
pAkt, Akt, and GluT4 were microwaved in boiling water for 2 minutes prior to loading into gel; total 
fraction samples to be probed for GluT3 and plasma membrane fraction samples were not microwaved. 
Following electrophoresis, gels were transferred to PVDF membranes at 350 mA for 1 hour at 4 °C. 
Membranes were blocked in 5% milk for 1 hour then were probed for GluT3 (Abcam, ab41525-100), 
GluT4 (Millipore, 07-1404), pAkt (Cell Signaling, 4060L), Akt (Cell Signaling, 4691L), or β-actin 
(Sigma, A1978) using monoclonal primary antibodies. Following primary incubation overnight at 4 °C, 
membranes were probed with the appropriate biotinylated secondary antibodies (Pierce) for 1 hour at 
room temperature and then with HRP strepdavidin (Pierce, 21130) for 1 hour at room temperature. 
Membranes were then exposed to chemiluminescent substrate (Pierce, 34078) before being developed. 
Analysis of western blots was done using ImageQuant TL software.  
2.9 Statistical analyses 
Statistical significance was determined using a two-tailed, two-sample equal variance Student’s t-Test. 
The test was performed using the TTEST function on Microsoft Excel. Data points which were more than 
two standard deviations away from the mean were deemed to be outliers and omitted from data 
presentation, with the exception of behavioral data points, which were omitted if more than one standard 
deviation away from the mean. 
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3. Results 
3.1 Animal weights 
Animal weights were monitored over the course of diet administration in order to observe the effects of 
the four diets on weight gain. Figure 1 shows weight gain from day 0 to day 59.5 of diet administration. 
Groups receiving high methionine (Hmet) and high methionine plus high fat/fructose diet (Hmet + HFD) 
were significantly (p < 0.005) lighter on day 59.5 than groups receiving either normal diet or HFD, but 
were not significantly different from each other. Similarly, groups receiving normal diet and HFD were 
not significantly different from each other on day 59.5. 
 
Figure 1. Animal weights from the first day of diet administration to day 59.5 of diet administration.  
High (2%) methionine is denoted “Hmet” (high methionine) and high fat diet plus high (20%) 
fructose water is denoted “HFD” (high fat/fructose diet). Animals on Hmet diet and Hmet + HFD 
were significantly lighter on day 59.5 of diet administration than animals on normal diet or HFD. 
N = 7-8 per group. 
3.2 Food and water intake 
Given early differences in weight between groups receiving high methionine and groups not receiving 
high methionine, and a lack of expected difference between the group receiving normal chow and the 
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group receiving HFD, food and water intake were monitored for a one week period during food 
administration. Figure 2a shows food intake in grams per animal per day. Animals receiving normal diet 
had the highest food intake whereas animals receiving Hmet + HFD had the lowest intake. All groups had 
significantly different intakes (p < 0.05). Figure 2b shows food intake in grams normalized to 100g body 
weight per day. Animals receiving normal diet and Hmet diet had a significantly – almost 2-fold – higher 
intake than animals receiving HFD and Hmet + HFD (p < 0.005); however, there was no significant 
difference in intake between either normal diet and Hmet diet or HFD and Hmet + HFD.  
 
 
Figure 2. a. Food intake in grams per animal per day. All groups were significantly different from each  
other (* p < 0.05). N = 4 (animals housed in pairs) per group. b. Food intake in grams per 100g 
body weight per day. Normal diet and Hmet were significantly higher than HFD and Hmet + 
HFD (** p < 0.005). N = 4 per group.  
In order to investigate the observed 2-fold higher food intake in animals not receiving high fat/fructose 
diet, water intake was measured to determine the number of calories obtained from fructose in the 
fructose drinking solution. Figure 3a shows water intake in grams normalized to 100g body weight per 
day. There were no significant differences in drinking water intake between groups. Figure 3b shows total 
caloric intake (food + drinking water, where applicable) normalized to 100g body weight per day.  
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Figure 3. a. Water intake in grams per 100g body weight per day. N = 4 per group. b. Total caloric intake  
per 100g body weight per day. N = 4 per group.  
Calories from fructose drinking water filled in the gap in food intake between animals not receiving 
fructose and animals receiving fructose in the drinking water. There were no significant differences in 
total caloric intake per day between groups.  
3.3 Body fat composition 
Epididymal fat pad was collected and weighed after decapitation to determine body fat composition. 
Body fat composition was calculated by creating a ratio of epididymal fat pad weight over total animal 
weight. Figure 4 shows the average ratio of epididymal fat pad weight over total animal weight 14 days 
prior to killing. 
 
Figure 4. Epididymal fat pad weight over total animal weight 14 days prior to killing. Normal diet and 
HFD had significantly more fat than Hmet and Hmet + HFD (* p < 0.05). N = 7-8 per group. 
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Animals receiving either of the high methionine diets had significantly (p < 0.05) – up to 2-fold – less fat 
than animals not receiving high methionine. There were no significant differences in body fat 
composition between Hmet and Hmet + HFD groups or between normal and HFD groups, although 
animals receiving HFD tended to have a higher body fat composition than animals receiving normal diet.  
3.4 Serum analyses 
To verify that hyperhomocysteinemia was induced in animals receiving a high methionine diet and to 
examine any differences in homocysteine levels between groups, serum homocysteine levels were 
determined. Figure 5 shows the group average concentrations of homocysteine in serum.  
 
Figure 5. Serum homocysteine concentrations. Animals on Hmet diet had significantly higher serum  
homocysteine levels than animals on normal diet, as did animals on HFD (* p < 0.05). Animals 
on Hmet + HFD had significantly higher serum homocysteine levels than animals on either 
normal diet or HFD (* p < 0.05). N = 7-8 per group.  
Animals on Hmet diet had significantly (p < 0.05) – over 3-fold – higher serum homocysteine levels than 
animals on normal diet. Animals on HFD also had significantly (p < 0.05) – about one-third – higher 
serum homocysteine levels than animals on normal diet. Animals on Hmet + HFD had significantly (p < 
0.05) – about 10-fold, on average – higher homocysteine levels than animals on normal diet or HFD, but 
did not have homocysteine levels that were significantly different from animals on Hmet diet. 
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Serum free fatty acids were also determined. Figure 6 shows average concentrations of free fatty acids in 
serum. There were no significant differences across groups. 
 
Figure 6. Serum free fatty acid concentrations. N = 7-8 per group.  
3.5 Glucose tolerance test 
During the week prior to surgery, all animals were tested for blood glucose levels to determine if the diets 
had any effect on blood glucose levels. Figure 7 shows average blood glucose levels, measured using 
blood obtained by tail-prick, for each group during week 7 of diet administration. Animals receiving 
Hmet diet had significantly higher blood glucose levels than animals receiving Hmet + HDF. 
 
Figure 7. Average blood glucose levels of each group during week 7 of diet administration. Animals on  
Hmet had significantly higher blood glucose levels than animals on Hmet + HFD (* p < 0.05).  
N = 7-8 per group. 
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To further investigate the effect of each diet on insulin signaling, a glucose tolerance test was performed. 
Figure 8 shows the results of the glucose tolerance test for each group.  
 
Figure 8. Glucose tolerance test results per group. Animals on Hmet diet, HFD, and Hmet + HFD had  
significantly elevated blood glucose levels at 30 minutes after injection (* p < 0.05); blood 
glucose levels at 60 minutes for animals on Hmet and HFD fell significantly from 30 minutes († p 
< 0.05). N = 4 per group.  
Animals receiving Hmet diet, HFD, and Hmet + HFD all experienced significantly (p < 0.05) elevated 
blood glucose levels from baseline 30 minutes after injection of glucose. At 60 minutes after injection, 
blood glucose levels had fallen significantly (p < 0.05) from 30 minutes in animals receiving Hmet diet 
and HFD but not in animals receiving Hmet + HFD, in which blood glucose remained elevated.   
3.6 Western blots 
To determine if the diets had any effect on the activity of hippocampal proteins involved in the insulin 
signaling cascade, western blots were performed on hippocampal brain tissue homogenate from each 
animal. Blots were probed for GluT3, GluT4, and Akt. Figure 9 shows western blot results for GluT3 (a) 
and GluT4 (b) translocation and Akt (c) phosphorylation (in total fraction), with each group expressed as 
a percentage of control (normal diet) group.  
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Figure 9. a. Ratio of plasma membrane (PM) fraction GluT3 over total fraction GluT3. N = 4 per group.  
b. Ratio of PM fraction GluT4 over total fraction GluT4, normalized over PM fraction over total 
fraction actin. N = 4 per group. c. Ratio of phosphorylated Akt (pAkt) over total Akt. Animals on 
Hmet + HFD had significantly lower levels of Akt phosphorylation than animals on either normal 
diet or HFD (* p < 0.05); animals on Hmet diet had significantly lower levels of Akt 
phosphorylation than animals on HFD (* p < 0.05). N = 4 per group. 
There were no significant differences in GluT3 or GluT4 translocation between groups, although there 
was a trend toward higher levels of GluT3 translocation in groups receiving Hmet diet, HFD, and Hmet + 
HFD; correlated with this, there was also a trend toward lower levels of GluT4 translocation in groups 
receiving Hmet diet, HFD, and Hmet + HFD. Animals receiving Hmet + HFD had significantly (p < 0.05) 
– about 2-fold – lower levels of Akt phosphorylation than animals receiving normal diet or HFD. 
0
50
100
150
200
250
P
M
 /
 T
o
ta
l 
G
lu
tT
3
, 
%
 c
o
n
tr
o
l
normal Hmet HFD Hmet + HFD
a
0
25
50
75
100
125
150
P
M
 /
 T
o
ta
l 
G
lu
tT
4
 /
 a
ct
in
, 
%
 c
o
n
tr
o
l
normal Hmet HFD Hmet + HFD
b
0
25
50
75
100
125
150
p
A
k
t 
/ 
A
k
t,
 %
 c
o
n
tr
o
l
c
normal Hmet HFD Hmet + HFD
*
**
  norm. Hmet   HFD  Hmet  
                  +HFD 
  norm. Hmet   HFD  Hmet  
                  +HFD 
  PM GluT3 
 
  total GluT3 
 
  pAkt 
 
  total Akt 
 
  PM GluT4 
 
  total GluT4 
 
  PM actin 
 
  total actin 
 
19 
 
Similarly, animals receiving Hmet diet had significantly (p < 0.05) lower levels of Akt phosphorylation 
than animals receiving HFD, although the levels were not significantly different from those of animals 
receiving normal diet.  
3.7 Behavioral testing 
All animals were subjected to a spatial cognitive task in the form of an elevated four-arm plus-maze 
during which arm entries were recorded for calculation of a spontaneous alternation score. The objective 
of performing this cognitive task was to determine how each diet affected spatial memory and cognitive 
ability. Figure 10 shows the average spontaneous alternation scores for each group. 
 
Figure 10. Spontaneous alternation scores for each group. Animals on Hmet diet, HFD, and Hmet + HFD  
had significantly lower scores than animals on normal diet (* p < 0.05). N = 5 for normal diet; N 
= 6 for Hmet diet; N = 7 for HFD; and N = 6 for Hmet + HFD.  
Animals were subsequently subjected to the open-field maze task to observe how each diet affected 
anxiety behavior. Figure 11 shows the average open-field scores for each group. Animals receiving Hmet 
+ HFD made significantly (p < 0.05) less center crossings than animals receiving either Hmet diet or 
HFD, but did not have significantly different numbers of center crossings from animals on normal diet. 
There was a non-significant trend toward more center crossings in animals receiving Hmet diet or HFD 
than in animals receiving normal diet.  
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Figure 11. Open-field score for each group. Animals on Hmet + HFD made significantly less center  
crossings than animals on either Hmet diet or HFD (* p < 0.05). N = 6 for normal diet, HFD, and 
Hmet + HFD; N = 4 for Hmet diet. 
3.8 Microdialysates  
Microdialysis was performed during the elevated four-arm plus-maze task to examine the metabolic state 
of the hippocampus prior to, during, and following the task. Figure 12 shows average glucose levels prior 
to (baselines, B1 – B3), during (maze, M), and following (post-maze, P1 – P3) the maze task for each 
group. There were no significant differences between groups. A significant (p < 0.05) “dip” in glucose 
levels during the maze task was observed only in animals receiving Hmet + HFD, although a small, non-
significant “dip” in glucose during the task did occur in animals receiving normal diet and Hmet diet.  
 
Figure 12. Hippocampal microdialysate glucose levels, expressed as a percent of baseline. N = 4 for  
normal diet; N = 3 for Hmet diet; N = 4 for HFD; and N = 7 for Hmet + HFD. 
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4. Conclusions 
In a rat model, a high methionine diet – with or without a high fat diet – is correlated with lower body 
weight and decreased food intake per animal. A high methionine diet coupled with a high fat diet results 
in a dramatically decreased food intake, with animals receiving Hmet + HDF eating almost 2-fold less 
than animals receiving a normal diet. Reduced food intake in animals receiving either of the high 
methionine diets was foreseen before the experiment (Fau et al., 1988) was started, but lower food intake 
in animals receiving Hmet + HFD had not been predicted. Results additionally showed that animals 
receiving HFD ate significantly less than animals receiving normal diet, which had also not been 
predicted nor observed by our lab before. When food intake was normalized to 100g of body weight, food 
intake was only significantly reduced in animals receiving a high fat diet, which prompted us to calculate 
the number of calories being obtained from high fructose drinking solution coupled to the high fat diet. 
Interestingly, total caloric intake was the same across all groups, indicating that reduced food intake in 
animals receiving a high fat diet was due to caloric intake from the drinking water. Fructose was initially 
added to the diet with the intention of de-regulating the body’s correlation between food intake and 
measured caloric intake, as the hypothalamus can neither uptake nor sense calories obtained from 
fructose, in order to maximize food intake and prevent the separation of diet-resistant animals from diet-
induced obese animals (Levin et al. 1997). Although separation within the group of animals receiving 
HFD did not occur, the results from this experiment suggest that fructose did not cause the desired de-
regulation, as caloric intake from food was adjusted by groups receiving a high fat diet to compensate for 
calories obtained from the drinking solution. These findings suggest a review of the known mechanisms 
by which the body senses caloric intake.  
Hyperhomocysteinemia ( > 20 µmol/L serum homocysteine levels) was successfully induced in animals 
receiving either of the high methionine diets. Although hyperhomocysteinemia was not induced in 
animals receiving HFD, the serum homocysteine levels of these animals were significantly higher than 
those of animals receiving normal diet, suggesting that the high fat plus high fructose diet played a role in 
the accumulation of free homocysteine in the blood stream. Indeed, animals receiving Hmet + HFD had 
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dramatically elevated serum homocysteine levels – more than 10-fold higher than those of animals 
receiving normal diet. However, the serum homocysteine levels of animals receiving Hmet + HFD were 
also highly variable and thus not significantly different from those of animals receiving Hmet diet. These 
results suggest that a high fat plus high fructose diet, or some consequence of this diet, can modulate the 
levels of serum homocysteine and, in some cases, yield dramatically elevated levels of homocysteine.  
Hyperhomocysteinemia was correlated with a decreased body fat composition, which was similar in both 
groups receiving high methionine, regardless of a high fat plus high fructose diet. Interestingly, the high 
fat plus high fructose diet did not induce body fat compositions that were significantly different from 
those of animals receiving a normal diet, although the animals receiving HFD tended to have a higher 
body fat composition. The high fat plus high fructose diet was expected to produce significant obesity in 
animals receiving this diet. It is possible that the type of fat used in the high fat diet does not produce 
obesity readily. Crude calculations of the fat composition of the high fat diet revealed that about 25% of 
the fat, obtained from butter and corn oil, is saturated fat, comprising about 4% of the weight of the diet. 
In contrast, about 30% of the fat in the normal diet is saturated fat, comprising about 1.75% of the weight 
of the diet. When food intake per 100g body weight of animal is taken into consideration, animals 
receiving HFD took in a significant 1.5 times more saturated fat, per weight, than animals on normal diet 
(data not shown). However, animals receiving HFD were not 1.5 times more obese than animals receiving 
normal diet, which indicates that other factors, such as genetics, were at play in their lack of obesity. 
Similarly, no significant trends in serum free fatty acid levels were observed, although these levels tend to 
be elevated in type 2 diabetes (Reitsma, 1967). This result may be related to the lack of obesity in animals 
receiving HFD.  
Blood glucose levels, like serum free fatty acid levels, also tend to be elevated in type 2 diabetes and this 
measure is commonly used to diagnose and monitor diabetes. However, after 7 weeks of diet 
administration, blood glucose levels were not significantly elevated in any of the groups. To determine 
insulin sensitivity, a glucose tolerance test was performed during week 9 of diet administration. Animals 
receiving Hmet diet, HFD, and Hmet + HFD were shown to have significantly elevated blood glucose 
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levels 30 minutes after I.P. injection of 1g/kg body weight glucose, whereas animals receiving normal diet 
did not show significantly elevated blood glucose levels 30 minutes after injection, suggesting impaired 
glucose tolerance and some level of deregulation in the insulin signaling cascade given the delayed 
response. Sixty minutes after injection, animals receiving Hmet diet and HFD had blood glucose levels 
that were significantly lower than those at 30 minutes after injection. This pattern of blood glucose levels 
following an injection of glucose is representative of a pre-diabetic phenotype. Finding an impaired 
glucose tolerance similar to animals receiving HFD in animals receiving Hmet diet suggests that 
hyperhomocysteinemia may play a role in modulating insulin sensitivity. Indeed, in animals receiving 
Hmet + HFD, blood glucose levels at 60 minutes were not significantly lower than those at 30 minutes 
after injection. This result suggests that animals on Hmet + HFD developed insulin resistance and were 
therefore glucose intolerant. More interestingly, taken as a whole, these results suggest that, by 
themselves, a high methionine diet and a high fat plus high fructose diet can lead to an impaired glucose 
tolerance condition after 9 weeks of diet administration but, when administered together, these diets 
accelerate the rate of development insulin resistance.  
Molecular data from western blots suggests that GluT4 translocation may be decreased in the 
hippocampus of animals receiving Hmet diet, HFD, and Hmet + HFD, although differences were not 
significant. This finding is correlated with findings from the glucose tolerance test and previous findings 
that GluT4 translocation is decreased in a state of impaired glucose tolerance and insulin resistance 
(James & Piper, 1994). Molecular data also showed that hippocampal Akt phosphorylation was 50% 
reduced in animals receiving either of the high methionine diets but was not impaired in animals receiving 
HFD. This result contradicts several others which have previously found that homocysteine activates the 
PI3K/Akt pathway (Chiang et al., 2011). However, these studies used acute exposure of non-neuron cell 
cultures to homocysteine. The present study used chronic exposure to homocysteine and suggests that 
chronic hyperhomocysteinemia may promote decreased Akt activation. Further investigation of this 
finding is necessary to reach a more conclusive understanding of the relationship between 
hyperhomocysteinemia and Akt phosphorylation.  
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Results from the elevated four-arm plus-maze task showed that cognitive spatial ability was impaired in 
animals receiving Hmet diet, HFD, and Hmet + HFD. No significant differences between these groups 
were observed, however, suggesting that the combination of high methionine and high fat plus high 
fructose does not cause a further cognitive impairment in animals receiving this treatment than that 
observed in animals receiving just one of these treatments. This result was surprising; it would be 
worthwhile to investigate how the combination of high methionine and high fat plus high fructose affects 
the physiology of the hippocampus. Results from the open-field task suggest that a high methionine diet 
and a high fat plus high fructose diet may lead to decreased anxiety, although the combination of the two 
seems to lead to increased anxiety; none of these results were significantly different from those of animals 
receiving normal diet. Decreased anxiety in animals receiving Hmet diet and HFD may be the result of 
decreased cognitive ability; increased anxiety in animals receiving Hmet + HFD may have been a shift to 
the right side of an inverted U-curve for cognitive ability and anxiety levels.  
Overall, the results from this study suggest there is a molecular relationship between homocysteine levels 
and insulin signaling. Serum homocysteine levels were significantly elevated in both animals receiving 
high methionine and in animals receiving high fat plus high fructose, although they were not elevated 
enough to diagnose hyperhomocysteinemia in the latter. In animals receiving Hmet + HFD, homocysteine 
levels were dramatically elevated, although highly variable; these findings, along with results from 
animals on HFD, suggest that the high fat plus high fructose diet, or a consequence of it (impaired glucose 
tolerance?) may modulate homocysteine levels. The finding of impaired glucose tolerance in animals 
receiving a high methionine diet seems to suggest that serum homocysteine levels can also modulate 
insulin sensitivity, yielding insulin resistance when combined with a high fat plus high fructose diet. 
Furthermore, hyperhomocysteinemia was correlated with a significant and dramatic decrease in Akt 
phosphorylation, which plays a major role in the insulin signaling pathway. Future studies should focus 
on determining the particular mechanisms by which homocysteine modulates the insulin signaling 
pathway and/or vice versa.  
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